Herrmann, J. Et Al. 2022. Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. European Heart Journal , vol.43, no.4 , 280-299.

Herrmann, J., Lenihan, D., Armenian, S., Barac, A., Blaes, A., Cardinale, D., ... Carver, J.(2022). Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. European Heart Journal , vol.43, no.4, 280-299.

Herrmann, Joerg Et Al. "Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement," European Heart Journal , vol.43, no.4, 280-299, 2022

Herrmann, Joerg Et Al. "Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement." European Heart Journal , vol.43, no.4, pp.280-299, 2022

Herrmann, J. Et Al. (2022) . "Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement." European Heart Journal , vol.43, no.4, pp.280-299.

@article{article, author={Joerg Herrmann Et Al. }, title={Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement}, journal={European Heart Journal}, year=2022, pages={280-299} }